| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 1 24-29, Copyright © 1992 by American Association of Immunologists
ARTICLES |
Y Lu, A Granelli-Piperno, JM Bjorndahl, CA Phillips and JM Trevillyan
Department of Veterans' Affairs Medical Center, Amarillo, TX.
CD28 is a 44-kDa homodimeric receptor expressed on the majority of T cells. Engagement of the CD28 receptor by soluble anti-CD28 mAb in conjunction with PMA causes the induction of lymphokine/cytokine production and proliferation in resting T cells via signal transduction pathways independent of the TCR. The precise nature of the biochemical events that occur after perturbation of the CD28 receptor remain unclear. We report evidence for the coupling of CD28 to a protein- tyrosine kinase pathway. Multivalent cross-linking of the CD28 receptor or stimulation by soluble CD28 mAb plus PMA, but not PMA or soluble CD28 mAb alone, reproducibly caused the rapid (within 2 min) tyrosine phosphorylation of a 100-kDa cellular substrate. In some experiments, additional cellular substrates of 110, 85, 74, 68, 56, 43, and 29 kDa were also observed. The tyrosine phosphorylation of these substrates was completely inhibited by 12 h pretreatment of T cells with herbimycin A, a selective inhibitor of src-family protein-tyrosine kinases. Pretreatment of T cells with herbimycin was without effect on CD28 surface expression but did inhibit CD28 mAb plus PMA-induced IL-2 mRNA levels, IL-2R(CD25) up-regulation, and cell proliferation. The inhibition of IL-2 mRNA levels was likely at the level of transcription, because herbimycin inhibited NF-AT, AP-1, and CD28RC but not NF-kappa B or OCT-1 binding activities to their respective IL-2 enhancer region sequences. Herbimycin did not inhibit PMA-dependent events including CD69 surface expression, NF-kappa B nuclear binding activity or the level of CD25 induced by PMA alone, supporting the notion that herbimycin is acting to inhibit a CD28 initiated or regulated protein-tyrosine kinase pathway(s).
This article has been cited by other articles:
|
|
 |
|
  E. Parra, T. Mustelin, M. Dohlsten, and D. Mercola Identification of a CD28 Response Element in the CD40 Ligand Promoter J. Immunol., February 15, 2001; 166(4): 2437 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Witherden, R. Boismenu, and W. L. Havran CD81 and CD28 Costimulate T Cells Through Distinct Pathways J. Immunol., August 15, 2000; 165(4): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Leung, L. Haughn, A. Veillette, R. G. Hawley, R. Rottapel, and M. Julius TCR{alpha}{beta}-Independent CD28 Signaling and Costimulation Require Non-CD4-Associated Lck J. Immunol., August 1, 1999; 163(3): 1334 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-T. Ni, M. J. Deeths, W. Li, D. L. Mueller, and M. F. Mescher Signaling Pathways Activated by Leukocyte Function-Associated Ag-1-Dependent Costimulation J. Immunol., May 1, 1999; 162(9): 5183 - 5189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tsuchida, S. J. Knechtle, and M. M. Hamawy CD28 Ligation Induces Tyrosine Phosphorylation of Pyk2 but Not Fak in Jurkat T Cells J. Biol. Chem., March 5, 1999; 274(10): 6735 - 6740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-C. Yang, M. Ghiotto, B. Barbarat, and D. Olive The Role of Tec Protein-tyrosine Kinase in T Cell Signaling J. Biol. Chem., January 8, 1999; 274(2): 607 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Okkenhaug and R. Rottapel Grb2 Forms an Inducible Protein Complex with CD28 through a Src Homology 3 Domain-Proline Interaction J. Biol. Chem., August 14, 1998; 273(33): 21194 - 21202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. B. Soares, L. Tsavaler, A. Rivas, and E. G. Engleman V7 (CD101) Ligation Inhibits TCR/CD3-Induced IL-2 Production by Blocking Ca2+ Flux and Nuclear Factor of Activated T Cell Nuclear Translocation J. Immunol., July 1, 1998; 161(1): 209 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Parra, K. McGuire, G. Hedlund, and M. Dohlsten Overexpression of p65 and c-Jun Substitutes for B7-1 Costimulation by Targeting the CD28RE Within the IL-2 Promoter J. Immunol., June 1, 1998; 160(11): 5374 - 5381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. C. Liao, S. Fournier, N. Killeen, A. Weiss, J. P. Allison, and D. R. Littman Itk Negatively Regulates Induction of T Cell Proliferation by CD28 Costimulation J. Exp. Med., July 21, 1997; 186(2): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Hutchcroft, B. Tsai, and B. E. Bierer Differential Phosphorylation of the T Lymphocyte Costimulatory Receptor CD28. ACTIVATION-DEPENDENT CHANGES AND REGULATION BY PROTEIN KINASE C J. Biol. Chem., June 7, 1996; 271(23): 13362 - 13370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.ço. Pagès, M. Ragueneau, S. Klasen, M. Battifora, D. Couez, R. Sweet, A. Truneh, S. G. Ward, and D. Olive Two Distinct Intracytoplasmic Regions of the T-cell Adhesion Molecule CD28 Participate in Phosphatidylinositol 3-Kinase Association J. Biol. Chem., April 19, 1996; 271(16): 9403 - 9409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gibson, A. August, D. Branch, B. Dupont, and G. B. Mills Functional LCK Is Required for Optimal CD28-mediated Activation of the TEC Family Tyrosine Kinase EMT/ITK J. Biol. Chem., March 22, 1996; 271(12): 7079 - 7083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Shahinian, K Pfeffer, K. Lee, T. Kundig, K Kishihara, A Wakeham, K Kawai, P. Ohashi, C. Thompson, and T. Mak Differential T cell costimulatory requirements in CD28-deficient mice Science, July 30, 1993; 261(5121): 609 - 612. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
